ArticleNeuromolecular medicine2022
G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma.
Barbara Kunzler Souza et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleNeuromolecular medicine2022
Barbara Kunzler Souza et al.PubMed ↗Publisher ↗
No numbers read from the abstract.